Collectively, these results suggest that cP104aa interacts with HNRNPK to upregulate c‐MYC expression by inhibiting WWP2‐mediated c‐MYC ubiquitination, thereby promoting RCC proliferation and metastasis. Here, MYC is linked to renal cell carcinoma.